Border Biomedical Research Center

$480,362G12FY2009RRNIH

University Of Texas El Paso, El Paso TX

Investigators

Linked publications & trials

Paper 37484813 Paper 35056727 Paper 33969279 Paper 33600455 Paper 33356823 Paper 33276541 Paper 33274824 Paper 32253249 Paper 32169899 Paper 32068112 Paper 31430698 Paper 31287998 Paper 31268249 Paper 31151129 Paper 31078924 Paper 30911415 Paper 30868536 Paper 30467445 Paper 30088262 Paper 30056617 Paper 29973498 Paper 29551523 Paper 29177674 Paper 29078766 Paper 29069089 Paper 28936016 Paper 28824387 Paper 28089843 Paper 28031536 Paper 27693373 Paper 27664344 Paper 27600772 Paper 27431232 Paper 27216501 Paper 27028089 Paper 26968444 Paper 26934653 Paper 26922323 Paper 26801203 Paper 26798309 Paper 26771494 Paper 26587369 Paper 26410073 Paper 26384953 Paper 25936521 Paper 25705724 Paper 25645924 Paper 25487015 Paper 25450237 Paper 25380396 Paper 25291074 Paper 25287304 Paper 25219894 Paper 25197824 Paper 25134773 Paper 25108798 Paper 25104352 Paper 24793944 Paper 24753260 Paper 24737042 Paper 24694367 Paper 24657568 Paper 24583081 Paper 24564983 Paper 24523409 Paper 24453460 Paper 24391838 Paper 24385950 Paper 24380801 Paper 24375813 Paper 24368029 Paper 24312681 Paper 24300173 Paper 24272524 Paper 24271047 Paper 24265445 Paper 24135238 Paper 24054156 Paper 24009050 Paper 23984070 Paper 23881220 Paper 23863943 Paper 23691038 Paper 23598043 Paper 23589290 Paper 23583696 Paper 23567891 Paper 23543815 Paper 23451206 Paper 23398536 Paper 23378701 Paper 23345239 Paper 23255787 Paper 23214914 Paper 23150662 Paper 23103411 Paper 23050848 Paper 23023583 Paper 22905672 Paper 22820414

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To advance basic and translational research capabilities through development of effective diagnostics, drugs and vaccines for emerging infectious diseases, drug abuse, bioterrorism, metabolic disorders and cancer.

View original record on NIH RePORTER →